MMSI

SEC source: 0001839410-26-000004 · form4-09092026_070921.xml · nonDerivative · entry 1

Lewis Sheri · CIK 0001839410 · EVP of Global Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,371

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 8,371 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest in three equal annual increments, one-third each, on the anniversaries of the award date. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001926221-26-000008 · form4-08252026_080835.xml · nonDerivative · entry 1

Peterson Neil W. · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,051

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.43 to $90.53, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001836958-26-000008 · form4-08252026_080835.xml · nonDerivative · entry 2

Voigt Michel J. · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,412

F2 · price: Represents a bona fide charitable gift of shares. No consideration was received for the transaction

SEC source: 0001926221-26-000006 · form4-08052026_050840.xml · nonDerivative · entry 1

Peterson Neil W. · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,551

SEC source: 0001836958-26-000006 · form4-06172026_010652.xml · nonDerivative · entry 2

Voigt Michel J. · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,062

F2 · price: Represents a bona fide charitable gift of shares. No consideration was received for the transaction

SEC source: 0001671772-26-000006 · form4-06082026_060641.xml · nonDerivative · entry 2

Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,132

F1 · price: Represents a bona fide charitable gift of shares. No consideration was received for the transaction

SEC source: 0001708144-26-000004 · form4-05212026_010507.xml · derivative · entry 4

Gunderson Thomas J. · CIK 0001708144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2026-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001708144-26-000004 · form4-05212026_010507.xml · derivative · entry 3

Gunderson Thomas J. · CIK 0001708144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,750 shares

Expires 2026-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001708144-26-000004 · form4-05212026_010507.xml · nonDerivative · entry 2

Gunderson Thomas J. · CIK 0001708144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The reported transactions involved the reporting person's exercise of stock options for an aggregate of 21,250 shares of common stock. The exercise prices were paid in cash, and no shares were sold in connection with the option exercises.

SEC source: 0001708144-26-000004 · form4-05212026_010507.xml · nonDerivative · entry 1

Gunderson Thomas J. · CIK 0001708144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,241

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The reported transactions involved the reporting person's exercise of stock options for an aggregate of 21,250 shares of common stock. The exercise prices were paid in cash, and no shares were sold in connection with the option exercises.

SEC source: 0001786127-26-000004 · form4-05192026_100548.xml · nonDerivative · entry 1

Ward Lynne N. · CIK 0001786127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,266

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001174531-26-000004 · form4-05192026_100534.xml · nonDerivative · entry 1

Ward Scott R. · CIK 0001174531 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,457

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001708144-26-000002 · form4-05192026_100517.xml · nonDerivative · entry 1

Gunderson Thomas J. · CIK 0001708144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,491

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001844301-26-000002 · form4-05192026_100502.xml · nonDerivative · entry 1

Evans Stephen C. · CIK 0001844301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,266

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001726511-26-000003 · form4-05192026_100548.xml · nonDerivative · entry 1

Kaiser Laura S. · CIK 0001726511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,352

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0002024006-26-000002 · form4-05192026_100547.xml · nonDerivative · entry 1

Perez Silvia M. · CIK 0002024006 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,040

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001451534-26-000002 · form4-05192026_100510.xml · nonDerivative · entry 1

Carpenter Lonny J. · CIK 0001451534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,824

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001121897-26-000002 · form4-05192026_100552.xml · nonDerivative · entry 1

McDonnell Michael R. · CIK 0001121897 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,852

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001649014-26-000002 · form4-05192026_100524.xml · nonDerivative · entry 1

Millner F. Ann Ed.D. · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,000

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0002072266-26-000004 · form4-05132026_050513.xml · nonDerivative · entry 2

Smith Christian Adam · CIK 0002072266 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By 401(k) Plan

Disclosed balance after: 2,220

F1 · ownership.nature: Represents plan holdings as of 05/11/2026.

SEC source: 0001786127-26-000002 · form4-05112026_050527.xml · nonDerivative · entry 1

Ward Lynne N. · CIK 0001786127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,809

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.395 to $62.815, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001671772-26-000004 · form4-05112026_050526.xml · nonDerivative · entry 1

Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: No plan indicated

Ownership: Indirect · By 401 (k) plan

Disclosed balance after: 2,000

SEC source: 0001429832-26-000004 · form4-05072026_080522.xml · nonDerivative · entry 1

Aronson Martha Goldberg · CIK 0001429832 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,792

SEC source: 0001742555-26-000004 · form4-05072026_080527.xml · nonDerivative · entry 2

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,843

SEC source: 0001836958-26-000004 · form4-05072026_080519.xml · nonDerivative · entry 1

Voigt Michel J. · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Indirect · By 401(k) Plan

Disclosed balance after: 2,265

F1 · ownership.nature: Represents plan holdings as of 05/05/2026.

SEC source: 0001671772-26-000002 · form4-03022026_070304.xml · nonDerivative · entry 4

Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,132

F4 · shares: The Reporting Person surrendered 5,778 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.

SEC source: 0001671772-26-000002 · form4-03022026_070304.xml · nonDerivative · entry 3

Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,910

F3 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2023.

SEC source: 0001671772-26-000002 · form4-03022026_070304.xml · nonDerivative · entry 2

Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,908

F2 · shares: Represents a grant of RSUs. The RSUs vest in two equal installments on each of the second and the third anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001671772-26-000002 · form4-03022026_070304.xml · nonDerivative · entry 1

Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,499

F1 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001926221-26-000004 · form4-03022026_070303.xml · nonDerivative · entry 3

Peterson Neil W. · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,000

F3 · shares: The Reporting Person surrendered 6,061 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.

SEC source: 0001926221-26-000004 · form4-03022026_070303.xml · nonDerivative · entry 2

Peterson Neil W. · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,061

F2 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2023.

SEC source: 0001926221-26-000004 · form4-03022026_070303.xml · nonDerivative · entry 1

Peterson Neil W. · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,059

F1 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001429832-26-000002 · form4-03022026_070302.xml · nonDerivative · entry 1

Aronson Martha Goldberg · CIK 0001429832 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,792

F1 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001836958-26-000002 · form4-03022026_070349.xml · nonDerivative · entry 5

Voigt Michel J. · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,127

F5 · shares: The Reporting Person surrendered 6,698 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.

SEC source: 0001836958-26-000002 · form4-03022026_070349.xml · nonDerivative · entry 4

Voigt Michel J. · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,825

F4 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2023.

SEC source: 0001836958-26-000002 · form4-03022026_070349.xml · nonDerivative · entry 3

Voigt Michel J. · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,823

F3 · shares: Represents a grant of RSUs. The RSUs vest in two equal installments on each of the second and the third anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001836958-26-000002 · form4-03022026_070349.xml · nonDerivative · entry 2

Voigt Michel J. · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,414

F2 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0002072266-26-000002 · form4-03022026_060356.xml · nonDerivative · entry 5

Smith Christian Adam · CIK 0002072266 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,334

F5 · shares: The Reporting Person surrendered 2,018 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.

SEC source: 0002072266-26-000002 · form4-03022026_060356.xml · nonDerivative · entry 4

Smith Christian Adam · CIK 0002072266 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,352

F4 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 03/31/2023.

SEC source: 0002072266-26-000002 · form4-03022026_060356.xml · nonDerivative · entry 3

Smith Christian Adam · CIK 0002072266 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,590

F3 · shares: Represents a grant of RSUs. The RSUs vest in two equal installments on each of the second and the third anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0002072266-26-000002 · form4-03022026_060356.xml · nonDerivative · entry 2

Smith Christian Adam · CIK 0002072266 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,181

F2 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001742555-26-000002 · form4-03022026_060353.xml · nonDerivative · entry 5

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,343

F5 · shares: The Reporting Person surrendered 5,778 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.

SEC source: 0001742555-26-000002 · form4-03022026_060353.xml · nonDerivative · entry 4

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,121

F4 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2023.

SEC source: 0001742555-26-000002 · form4-03022026_060353.xml · nonDerivative · entry 3

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,119

F3 · shares: Represents a grant of RSUs. The RSUs vest in two equal installments on each of the second and the third anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001742555-26-000002 · form4-03022026_060353.xml · nonDerivative · entry 2

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,506

F2 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001926221-26-000002 · form4-01082026_050125.xml · derivative · entry 3

Peterson Neil W. · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2026-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2024.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 04/25/2020.

SEC source: 0001926221-26-000002 · form4-01082026_050125.xml · nonDerivative · entry 2

Peterson Neil W. · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,369

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2024.

SEC source: 0001926221-26-000002 · form4-01082026_050125.xml · nonDerivative · entry 1

Peterson Neil W. · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,369

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2024.

SEC source: 0000901534-25-000011 · form4-11262025_081100.xml · nonDerivative · entry 4

Lampropoulos Fred P. · CIK 0000901534 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,019,955

F3 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.00 to $88.175, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0000901534-25-000009 · form4-11242025_111128.xml · nonDerivative · entry 4

Lampropoulos Fred P. · CIK 0000901534 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,029,955

F3 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.0000 to $87.6708, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.